Outcomes of patients according to genetic risk at diagnosis and disease status at transplantation. (A) Cumulative incidence of NRM according to genetic risk at diagnosis (green line, favorable/intermediate genetic risk; red line, adverse genetic risk at diagnosis). (B) Cumulative incidence of relapse according to genetic risk at diagnosis (orange line, favorable/intermediate genetic risk; gray line, adverse genetic risk at diagnosis). (C) Moderate/severe cGVHD/relapse-free survival (by Kaplan-Meier curve) according to genetic risk at diagnosis (purple line, favorable/intermediate genetic risk [RISK⁻]; blue line, adverse genetic risk at diagnosis [RISK⁺]). (D) Cumulative incidence of NRM according to disease status at transplantation (red line, MRD⁺/active disease; green line, MRD⁻). (E) Cumulative incidence of relapse according to disease status at transplantation (lavender line, MRD⁺/active disease; orange line, MRD⁻). (F) Moderate/severe cGVHD/relapse-free survival according to disease status at transplantation (green line, MRD⁺/active disease; blue line, MRD⁻).